Automation Recursion Secures $1.6 Million NIH Phase 2 SBIR Grant to Identify Therapeutic Candidates for… AIT News Desk Nov 9, 2018 Recursion Pharmaceuticals, a biotechnology company that combines artificial intelligence (AI), experimental biology, and automation to discover and…
Arguments Against AI Recursion Pharmaceuticals Named One of Utah’s 2018 Top Workplaces by the Salt Lake Tribune AIT News Desk Nov 6, 2018 Award Coincides with the Opening of Recursion's Expansive New R&D Facility Recursion Pharmaceuticals, a biotechnology company that combines…